ATTENTION AGENCIES




DMNews Global Creative Jam
Featured speakers: 
Barbara Goodstein, CIO & EVP for AXA Equitable
Kevin Joyce, VP, Eastman Kodak Company
 
TIME IS RINNING OUT.
Register now for the DMNews Jam and receive complimentary attendance to the Caples Awards dinner.  
CLICK HERE to register today. 

WEBCAST


New adventures in ROI measurement

Date: Thursday, March 26, 2009
Time: 2pm EST/11am PST

Click here to register for free

Featured Speaker:
Mauricio Ferreira, PhD, Head of Marketing Science Group, Hypothesis
Asaf Evenhaim, CEO, Chief Executive Officer, Crossix Solutions Inc.
Mike Wojeck, Vice President of Strategic Solutions, RealAge, Inc.

Sponsored by RealAge 

ENTER THE MM&M AWARDS




Don't miss your chance to prove to the industry and your clients who produces the best work. You must enter to win. The deadline for submissions is Friday, June 5. Click here to submit your entry today.

MM&M PODCAST SERIES


Do you love your job? Or do your loathe it?

Is your career on track? Are you making enough money? As much as your peers? What are you going to do next? Complete the MM&M Career & Salary Survey 2009 now for a chance to win a $250 American Express gift card. All responses are confidential.
Click here to take the survey.

TOP JOBS

To find out about the MM&M Careers Section contact:
Scott Dattoli at 646-638-6015

New Drug Dossier

Click here to subscribe

MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. 

white Papers







MM&M Service Directory Featured Company


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


Subscribe to MM&M


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

MedPAC calls for reporting of samples

An influential advisory board urged Congress to impose far-reaching transparency rules on payments to healthcare professionals and organizations interacting with the drug industry--including reporting samples, in part to aid counterdetailing efforts.
 

GSK ads for Avodart are misleading, says FDA

Consumer ads in support of GSK's prostate drug Avodart overstate its efficacy and present misleading claims, the FDA said.
 

Most parents learn of HPV vaccine via DTC advertising: study

A majority of parents and healthcare providers of young women are aware of human papillomavirus (HPV), and most of them learned of the HPV vaccine through drug advertising, a UNC study found.
 

Cline, Davis & Mann launches CDM World Agency

Cline, Davis & Mann is going global with the launch of CDM World Agency, an international healthcare agency network with offices in Europe and Brazil and plans to expand into China, Japan, Mexico and Canada.
 

FROM OUR SPONSORS


Search has Changed. It's Time for Healthcare Marketers to Stand Up and Take Notice. Incorporating social media into your search marketing efforts is no longer a luxury. Today, it's a necessity if you want your healthcare organization to be found online. Learn how to optimize your online presence and more in Oneupweb's FREE paper, The Fusion of Search and Social Media.

In Brief

People News

Eli Lilly announced the promotion of Alex Azar, currently SVP, corporate affairs and communications, to vice president of business-to-business and Puerto Rico. In his new role, Azar will oversee Lilly's public payer, managed care and wholesaler operations in the US, as well as sales and marketing operations in Puerto Rico.
 

Company News

Pfizer and Bausch & Lomb announced a co-promotion deal for both companies' prescription ophthalmic pharmaceuticals in the US. The five year agreement includes Pfizer's Xalatan, and Bausch & Lomb's Alrex, Lotemax, Zylet, and the company's investigational anti-infective eye drop, besifloxacin ophthalmic suspension (0.6%), which is currently under FDA review.
 

Latest Features

MM&M Awards: Who's Going to Shine in 2009

The road to success in the MM&M Awards starts here with the launch of the 2009 program. And it promises to be bigger, better, fairer and more meaningful than ever. James Chase reports
 

Direct Marketing Report: The User Experience

Pharma direct marketing campaigns continue to shift focus away from the brand message and toward the user experience. Anthony Vecchione looks at the examples of Suboxone and Similac
 

2009 MAHF Inductees

The Medical Advertising Hall of Fame will induct Ron Pantello, Harry Sweeney and David Wood at a special celebration dinner.
 

Stent Wars

After hitting a rough patch for several years, established cardiac stent manufacturers are bracing for some intense competition as new players and devices enter the market. Anthony Vecchione examines the revitalized market and how these stents will be marketed
 

Headliner: Sanford C. Bernstein's Tim Anderson, MD

In his first year of med school, Tim Anderson, MD, VP, global pharmaceuticals analyst at Sanford C. Bernstein & Co., realized that medicine wasn't as exciting as he had hoped.
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.